BCAT Stock Analysis: BlackRock Capital | NYSE
Asset Management | NYSE, USA | Market Cap: 1.467m USD | 12M Return: 11.4% | US09260U1097 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 6.72M
Rev. Trend: 63.9%
Warnings
Tailwinds
No distinct edge detected
Seasonality 6.1 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
| Net Income: 222.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.18 > 0.02 and ΔFCF/TA -1.01 > 1.0 |
| NWC/Revenue: -93.82% < 20% (prev -100.9%; Δ 7.09% < -1%) |
| CFO/TA 0.18 > 3% & CFO 329.5m > Net Income 222.0m |
| Net Debt/EBITDA: error (cannot be calculated) |
| Current Ratio: 0.04 > 1.5 & < 3 |
| Outstanding Shares: last quarter (105.8m) vs 12m ago -1.50% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 12.18% > 50% (prev 10.59%; Δ 1.58% > 0%) |
| Interest Coverage Ratio: 155.5 > 6 (EBIT TTM 222.0m / Interest Expense TTM 1.43m) |
| A: -0.12 (Total Current Assets 7.82m - Total Current Liabilities 219.0m) / Total Assets 1.83b |
| B: 0.08 (Retained Earnings 151.8m / Total Assets 1.83b) |
| C: 0.12 (EBIT TTM 222.0m / Avg Total Assets 1.85b) |
| D: 6.23 (Book Value of Equity 1.58b / Total Liabilities 253.2m) |
| Altman-Z'' = 6.86 = AAA |
As of November 14, 2026, the stock is trading at USD 12.95 with a total of 454,671 shares traded. Over the past week, the price has changed by -2.44%, over one month by -1.54%, over three months by -14.12% and over the past year by +11.41%.
Current recommended Stop Loss: 12.50 (which is 3.5% or 1.5 ATR below the current price).
BlackRock Capital has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold BCAT.
- StrongBuy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
P/E Trailing = 5.7605
P/S = 5.7045
P/B = 0.9184
Revenue TTM = 225.0m USD
EBIT TTM = 222.0m USD
EBITDA TTM = 222.0m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.46b USD (1.47b + (null Debt) - CCE 7.78m)
Interest Coverage Ratio = 155.5 (Ebit TTM 222.0m / Interest Expense TTM 1.43m)
EV/FCF = 4.43x (Enterprise Value 1.46b / FCF TTM 329.5m)
FCF Yield = 22.58% (FCF TTM 329.5m / Enterprise Value 1.46b)
FCF Margin = 146.4% (FCF TTM 329.5m / Revenue TTM 225.0m)
Net Margin = 98.65% (Net Income TTM 222.0m / Revenue TTM 225.0m)
Gross Margin = unknown ((Revenue TTM 225.0m - Cost of Revenue TTM 1.43m) / Revenue TTM)
Tobins Q-Ratio = 0.80 (Enterprise Value 1.46b / Total Assets 1.83b)
Interest Expense / Debt = unknown (Interest Expense 1.43m / Debt none)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 175.4m (EBIT 222.0m * (1 - 21.00%))
Current Ratio = 0.04 (Total Current Assets 7.82m / Total Current Liabilities 219.0m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 222.0m)
Debt / FCF = unknown (Net Debt none / FCF TTM 329.5m)
Total Stockholder Equity = 1.63b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.01% (Net Income 222.0m / Total Assets 1.83b)
RoE = 13.59% (Net Income TTM 222.0m / Total Stockholder Equity 1.63b)
RoCE = 13.78% (EBIT 222.0m / Capital Employed (Total Assets 1.83b - Current Liab 219.0m))
RoIC = 10.94% (NOPAT 175.4m / Invested Capital 1.60b)
WACC = 7.91% (E(1.47b)/V(1.47b) * Re(7.91%) + (debt-free company))
Discount Rate = 7.91% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -90.96 | Cagr: -2.34%
[DCF] Terminal Value 74.41% ; FCFF base≈339.7m ; Y1≈320.6m ; Y5≈300.1m
[DCF] Fair Price = 44.22 (EV 4.73b - Net Debt 0.0 = Equity 4.73b / Shares 107.0m; r=8.35% [WACC [floored]]; 5y FCF grow -7.15% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: 63.87 | Revenue CAGR: 4.29% | SUE: N/A | # QB: 0